INSIDER · CIK 1350090
Lieber Jonathan I
Chief Financial Officer at Rallybio Corp (RLYB) · Director at Decoy Therapeutics Inc. (DCOY)
↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$10KSold on the market
2Companies
Oct 28, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 202617:03 | Oct 27, 2026 | RLYBRallybio Corp | Chief Financial Officer | S · Sell | $16.04 | −599 | 15,551 | -4% | −$10K | ||
| Oct 28, 202617:03 | Oct 26, 2026 | RLYBRallybio Corp | Chief Financial Officer | A · Grant | — | +2,500 | 16,150 | +18% | — | ||
| Oct 13, 202616:50 | Oct 9, 2026 | RLYBRallybio Corp | Chief Financial Officer | M · Exercise | $6.08 | +3,910 | 13,650 | +40% | $24K | ||
| Oct 1, 202617:32 | Sep 29, 2026 | RLYBRallybio Corp | Chief Financial Officer | M · Exercise | $6.08 | +5,000 | 9,740 | +105% | $30K | ||
| Sep 2, 202618:32 | Aug 31, 2026 | DCOYDecoy Therapeutics Inc. | Director | A · Grant | — | +2,000 | 2,002 | +100000% | — |